1) HCFU-SLN
卡莫氟固脂纳米粒
1.
Preparation of HCFU-SLNs and Reversion of Multidrug Resistance to Human Carcinoma Line in vitro;
卡莫氟固脂纳米粒的制备及其体外逆转人大肠癌细胞多药耐药性研究
2) Solid Lipid Nanoparticles
固脂纳米粒
1.
Determination of Entrapment Efficiency and Drug Loading of Brucine Solid Lipid Nanoparticles Lyophilized Powder by HPLC
HPLC法测定马钱子碱固脂纳米粒冻干粉的包封率和载药量
3) Solid lipid nanoparticles
固体脂质纳米粒
1.
Preparation of solid lipid nanoparticles containing praziquantel;
吡喹酮固体脂质纳米粒的研制
2.
Optimizing for preparation technique of oleanolic acid solid lipid nanoparticles by orthogonal test;
正交试验法优选齐墩果酸固体脂质纳米粒的制备工艺
3.
Preparation and anti-fibrotic effects of solid lipid nanoparticles loaded with silibinin;
水飞蓟宾固体脂质纳米粒的制备及抗肝纤维化作用
4) SLN
固体脂质纳米粒
1.
The development of the solid lipid nanoparticles (SLN) as a pharmaceutical carrier is reviewed.
对固体脂质纳米粒(SLN)作为药物载体的最新研究进展进行了综述,指出SLN在药学领域的广阔 发展前景。
2.
OBJECTIVE: To prepare Berberine hydrochloride solid lipid nanoparticles(BH-SLN).
目的:制备盐酸小檗碱固体脂质纳米粒(BH-SLN)。
3.
Solid lipid nanoparticles (SLN) are nanoparticles generally made from solid lipids by high pressure homogenization.
固体脂质纳米粒通常是由固体脂质材料经高压乳匀法制备而成。
5) solid lipid nanoparticle
固体脂质纳米粒
1.
Preparation of stearic acid solid lipid nanoparticles containing podophyllotoxin;
鬼臼毒素硬脂酸固体脂质纳米粒的制备
2.
Preparation of silymarin solid lipid nanoparticles;
水飞蓟素固体脂质纳米粒的制备
3.
Preparation of solid lipid nanoparticles containing the volatile oil of Lignum Dalbergia odoriferae;
降香挥发油固体脂质纳米粒的制备工艺研究
6) Solid lipid nanoparticles(SLN)
固体脂质纳米粒
1.
Concentrations of β-elemene at 1 h after iv administration of solid lipid nanoparticles(SLN)and emulsion to H22-bearing mice were determined respectively.
目的:建立小鼠肿瘤中β-榄香烯的含量分析方法并测定静脉给予β-榄香烯固体脂质纳米粒和乳剂1h后小鼠肿瘤中β-榄香烯的浓度。
2.
One system included two types of conventional O/W emulsions;the other three kinds of solid lipid nanoparticles(SLN).
目的:研究两类载体系统的紫外保护效果,其中一类载体为传统的O/W乳液,另一类为固体脂质纳米粒(SLN)。
3.
Methods nanoemulsion(NM),solid lipid nanoparticles(SLN) and nanostructured lipid carrier(NLC) were prepared.
方法采用高压均质法制备3种不同类型的纳米脂质载体体系,分别为纳米乳液(NM)、固体脂质纳米粒(SLN)和纳米结构脂质载体(NLC),并用透射电镜(TEM)、粒度分析仪(PCS)和高效液相色谱(HPLC)仪对其进行表征。
补充资料：卡莫氟
分子式：C11H16FN3O3
分子量：暂无
CAS号：61422-45-5
性质：暂无
制备方法：暂无
用途：是5-氟脲嘧啶系列的第三代抗癌药，对多种实体瘤和腹水瘤均有较强的抑制作用。
分子量：暂无
CAS号：61422-45-5
性质：暂无
制备方法：暂无
用途：是5-氟脲嘧啶系列的第三代抗癌药，对多种实体瘤和腹水瘤均有较强的抑制作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条